A quiet pharmaceutical revolution is reshaping the grocery aisle—and with it, demand signals across the agri-food supply chain. GLP-1 drugs, originally developed for treating Type 2 diabetes, are now increasingly being used for weight loss, with about 12 per cent of adults in North America currently using them. That number is expected to grow quickly,... Read More